Robert L. Nussbaum - Apr 3, 2023 Form 4 Insider Report for Invitae Corp (NVTA)

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Stock symbol
NVTA
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
4
Date filed
4/5/2023, 08:29 PM
Previous filing
Mar 15, 2023
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Award $0 +155K +34.61% $0.00 603K Apr 3, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issuable upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3 of the total award vesting on each of May 15, 2024, 2025 and 2026, subject to continued service with the issuer through the applicable vesting dates.
F2 Includes an aggregate of 427,028 shares of common stock issuable pursuant to restricted stock units that have not vested.